Xencor (XNCR) Cash from Investing Activities Growth (1y) (2014 - 2026)
Xencor (XNCR) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | 95.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.18% |
| Dec 31, 2025 | 24.32% |
| Sep 30, 2025 | 108.97% |
| Jun 30, 2025 | -38.69% |
| Mar 31, 2025 | -57.71% |
| Dec 31, 2024 | 128.18% |
| Sep 30, 2024 | -460.63% |
| Jun 30, 2024 | 4,798.65% |
| Mar 31, 2024 | -32.87% |
| Dec 31, 2023 | -927.48% |
| Sep 30, 2023 | 1,350.43% |
| Jun 30, 2023 | 98.14% |
| Mar 31, 2023 | 167.09% |
| Dec 31, 2022 | 212.32% |
| Sep 30, 2022 | 108.04% |
| Jun 30, 2022 | -41.89% |
| Mar 31, 2022 | -288.60% |
| Dec 31, 2021 | -90.02% |
| Sep 30, 2021 | 23.16% |
| Jun 30, 2021 | -189.73% |